Sulphonated biomaterials as glycosaminoglycan mimics in wound healing

Advanced Wound Repair Therapies

Volumn , Issue , 2011, Pages 321-357

  Tighe, B J ^a   Mann, A ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Biomimesis; Hydrogel; Interfacial tension; Proteoglycan; Sulphate; Sulphonate

Indexed keywords

EID: 84895068556     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9780857093301.2.321     Document Type: Chapter

References (60)

1. Bahia R.K. Skin adhesive hydrogels for the topical delivery of active agents 2008, Aston University, Birmingham, UK, Thesis.
2. Bayraktar H., Akal E., Sarper O., Varnali T. Modeling glycosaminoglycans-hyaluronan, chondroitin, chondroitin sulphate A, chondroitin sulphate C and keratan sulphate. J Mol Structure:Theochem 2004, 683:121-132.
3. Benning B.K. Novel high water content hydrogels 2000, Aston University, Birmingham, UK, Thesis.
4. Boote N.D. Photopolymerisation of sheet hydrogels: A mechanistic study 2007, Aston University, Birmingham, UK, Thesis.
5. Botos I., Scapozza L., Zhang D., Liotta L.A., Meyer E.F. Batimastat, a potent matrix metalloproteinase inhibitor, exhibits an unexpected mode of binding. Procs Nat Acad Sci USA 1996, 93:2749-2754.
6. Brulez B. Biomimetic prosthetic ligament and production method thereof 2004, WO200406705, 2004-08-12.
7. Drotleff S., Lungwitz U., Breunig M., Dennis A., Blunk T., Tessmar J., Gopferich A. Biomimetic polymers in pharmaceutical and biomedical sciences. Eur J Pharm Biopharm 2004, 58:385-407.
8. Essler A., Nisbet L. Active wound dressing materials 2007, W02007068885, to Ethicon Inc (US).
9. Fleming M.C. Skin adhesive hydrogels for biomedical applications 1999, Aston University, Birmingham, UK, Thesis.
10. Gilbert M.E., Kirker K.R., Gray S.D., Ward P.D., Prestwich G.D., Orlandi R.R. Chrondroitin sulphate hydrogel and wound healing in rabbit maxillary sinus mucosa. Laryngoscope 2004, 114:1406-1409.
11. Gipson I.K. Distribution of mucins at the ocular surface. Exp Eye Res 2004, 78:379-388.
12. Gozzo A.J., Nunes V.A., Carmona A.K., Nader H.B., von Dietrich C.P., Silveira V.L.F., Shimamoto K., Ura N., Sampaio M.U., Sampaio C.A.M., Araujo M.S. Glycosaminoglycans affect the action of human plasma kallikrein on kininogen hydrolysis and inflammation. Int Immunopharmacology 2002, 2:1861-1865.
13. Hill D.H., Ottersbach P., Djavid G., Jozefowicz M., Migonney V., Vairon J.-P. Preparation of carboxylate-sulphonate polymers having cell proliferation-promoting properties. United States Patent 2002, 6365692.
14. Jani M., Tordai H., Trexler M., Banyai L., Patthy L. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2. Biochimie 2005, 87:4385-4392.
15. Johnson, Johnson Vision Care (US) Antimicrobial surfaces for ophthalmic devices 2004, WO2004094075, 2004-11-04.
16. Karim S. New low molecular weight sulphated polysaccharides 2005, FR2871476 -2005.
17. Kirker K.R., Luo Y., Morris S.E., Shelby J., Prestwich G.D. Glycosaminoglycan hydrogel films as supplemental wound dressings for donor sites. J Burn Care Rehabil 2004, 25:276-286.
18. Kisilevsky R., Lemieux L.J., Fraser P.E., Kong X., Hultin P.G., Szarek W.A. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nat Med 1995, 1:143-148.
19. 2 integrins. J Clin Invest 1997, 100:1725-1733.
20. Lavik E., Langer R. Tissue engineering: current state and perspectives. App Microbiol Biotech 2004, 65:1-8.
21. Leveugle B., Scanameo A., Ding W., Fillit H. Binding of heparan sulfate glycosaminoglycan to ß-amyloid peptide: inhibition by potentially therapeutic polysulfated compounds. NeuroReport 1994, 5:1389-1392.
22. Lima A.P.C.A., Almeida P.C., Tersariol I.L.S., Schmitz V., Schmaier A.H., Juliano L., Hirata I.Y., Müller-Esterl W., Chagas J.R., Scharfstein J. Heparan sulphate modulates kinin release by Trypanosoma cruzi through the activity of cruzipain. J Biol Chem 2002, 277:5875-5881.
23. Mahomed A. Ionic and neutral hydrogels for dermal and ophthalmic applications 2005, Aston University, Birmingham, UK, Thesis.
24. Michelacci Y.M. Collagens and proteglycans of the corneal extracellular matrix. Braz J Med Res 2003, 38:1037-1046.
25. Miksch K., Liwarska-Bizukojc E., Malachowska-Jutsz A., Kalka J. Acute toxicity and genotoxicity of five selected anionic and nonionic surfactants. Chemosphere 2005, 58:1249-1253.
26. Minett W.T. Cell adhesion on synthetic polymer substrates 1986, Aston University, Birmingham, UK, Thesis.
27. Mostow E.N., Haraway G.D., Dalsing M., Hodde J.P., King D. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg 2005, 41:856-862.
28. Munro H.S. Modulation of proteases. Particularly in the treatment of chronic ulcerous skin lesions 2010, US2010183722 (A1) - 2010-07-22.
29. Munro H.S. Treatment of inflammation and the complement and kinin cascades in a patient, particularly in chronic ulcerous skin lesions 2010, US2010143478 (A1) - 2010-06-10.
30. Munro H.S., Andrews P. Compositions for use as or in wound dressings 2010, WO2010007436 (A2) - 2010-01-21.
31. Munro H.S., Andrews P. Hydrogel composites and wound dressings 2010, WO2009098518 (A2) - 2009-08-13.
32. Nalampang K., Molloy R., Suebsanit N. Design and preparation of synthetic hydrogels for biomedical use as wound dressings 2006, Thailand Science Park Convention Center, Bangkok, April (published online).
33. Nalampang K., Molloy R., Witthayaprapakorn C., Suebsanit N. Design and preparation of AMPS-based hydrogels for biomedical use as wound dressings. Chiang Mai Journal Sci 2007, 34:183-189.
34. Orgill D.P., Straus F.H., Lee R.C. The use of collagen-GAG membranes in reconstructive surgery. Annals NY Acad Sci 1999, 888:233-248.
35. Patey S.J., Yates E.A., Turnbull J.E. Novel heparan sulphate analogues: inhibition of β-secretase cleavage of amyloid precursor protein. Biochem Soc Trans 2005, 33:1116-1118.
36. Peplow P.V. Glycosaminoglycan: a candidate to stimulate the repair of chronic wounds. Thrombosis Haemostasis 2005, 94:4-16.
37. Prestwich D. Glycosaminoglycan hydrogel films as biointeractive dressings for wound healing. Biomaterials 2002, 23:3661-3671.
38. Renné T., Dedio J., David G., Müller-Esterl W. High molecular weight kininogen utilizes heparan sulphate proteoglycans for accumulation on endothelial cells. J Biol Chem 2000, 275:33688-33696.
39. Renné T., Müller-Esterl W. Cell surface-associated chondroitin sulphate proteoglycans bind contact phase factor H-kininogen. FEBS Letters 2001, 500:3640.
40. Romanelli M.D., Valentina B., Maria S. Randomized comparison of Oasis wound matrix versus moist wound dressing in the treatment of difficult-to-heal wounds of mixed arterial/venous etiology. Adv Skin Wound Care 2010, 23:34-38.
41. Sergio D., Rosenzweig M.D., Holland S.M. Phagocyte immunodeficiencies and their infections. J Allergy Clin Immunol 2004, 113:620-626.
42. Shimabayashi S., Okuda M., Yagiu M., Nakagaki M. A comparison study between sodium decyl sulphonate and sodium decyl sulphate with respect to the interaction with poly(vinylpyrrolidone). Prog Colloid Polymer Sci 2003, 122:113-121.
43. Shu X.Z., Liu Y., Palumbo F., Luo Y., Prestwich G.D. In situ crosslinkable glycosaminoglycan hydrogels for tissue engineering. Biomaterials 2004, 25:13391348.
44. Shu X.Z., Ahmad S., Liu Y., Prestwich G.D. Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices (sECMs) for tissue engineering. J Biomed Mater Res 2006, 79A:902-912.
45. Steinhart J., Reynolds J. Multiple equilibria in proteins 1969, Acac. Press, N.Y.
46. Sundaram S., Lim F., Cooper S.L., Colman R.W. Role of leucocytes in coagulation induced by artificial surfaces: investigation of expression of MAC-1, granulocyte elastase and leucocyte adhesion on modified polyurethanes. Biomaterials 1996, 17:1041-1047.
47. Tighe B.J., Nasso M., Benning B., Molock F.J. Polymeric compositions comprising at least one volume excluding polymer 2008, US 20080114123.
48. Tighe B.J., Franklin V.J., Lydon F.J., Roberts S., Urban J.P.G., Sarit S. Intervertebral Disc and Intraocular Lens 2009, WO/2009/127844.
49. Tirrell M., Kokkoli E., Biesalski M. The role of surface science in bioen-gineered materials. Surface Sci 2002, 500:61-83.
50. Tomiyama S. Fundamental study of biochemical behavior of anionic sulphonate and sulphate-type surfactants. J Am Oil Chemists' Soc 1975, 52:135-138.
51. Vaheri A., Bizik J., Salonen E.M., Tapiovaara H., Siren V., Myohanen H., Stephens R.W. Regulation of the pericellular activation of plasminogen and its role in tissue-destructive process. Acta Ophthalmol 2002, 70:34-41.
52. Vachon D.J. Sulphonated styrene polymers for medical articles and barrier web constructs 2006, US2006292208, 2006-12-28.
53. Vachon D.J., Wnek G. Sulphonated styrene copolymers for medical uses 2004, to Aegis Biosciences, US2004142910, 2004-07-22.
54. Vachon D.J., Yager D.R. Novel sulfonated hydrogel composite with the ability to inhibit proteases and bacterial growth. J Biomed Mater Res A 2006, 76:35-43.
55. Venkatesan A.M., Baker J.L. N-hydroxy-2-(alkyl, aryl, or heteroaryl sulphanyl, sulphinyl, or sulphonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors 2002, to American Cyanamid Co, US2002188120, 2002-12-12.
56. Wang T.W., Sun J.-S., Wu H.-C., Huang Y.-C., Lin F.-H. Biomimetic bilayered gelatin-chondroitin 6 sulphate-hyaluronic acid biopolymer as a scaffold for skin equivalent tissue engineering. Artificial Organs 2006, 30:141-149.
57. Wang X., Fu X., Brown P.D., Crimmin M.J., Hoffman R.M. Matrix metal-loproteinase inhibitor BB-94 (Batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 1994, 54:4726-4728.
58. Whitfield D.M., Sarkar B. Heavy metal binding to heparin disaccharides. II. First evidence for zinc chelation. Biopolymers 2004, 32:597-619.
59. Wichterle O., Lim D. Hydrophilic gels for biological use. Nature 1960, 185:117-118.
60. Wichterle O., Lim D. Method for producing shaped articles from three dimensional hydrophilic polymers 1961, US Patent 2 976 576.